Showing results (1-10 of 134) with videos related to
Sort By:
Pageof 14
International Journal of Nephrology|January 31, 2012
Recurrent focal segmental glomerulosclerosis: a discrete clinical entityElena Torban, Martin Bitzan, Paul GoodyerPediatric Nephrology (Berlin, Germany)|April 28, 2012
TNFα pathway blockade ameliorates toxic effects of FSGS plasma on podocyte cytoskeleton and β3 integrin activationMartin Bitzan, Sima Babayeva, Anil Vasudevan, et al.American Journal of Physiology. Renal Physiology|November 2, 2023
Wilms' tumor gene 1: lessons from the interface between kidney development and cancerElena Torban, Paul GoodyerAnnual Review of Medicine|November 4, 2008
The kidney and ear: emerging parallel functionsElena Torban, Paul GoodyerPediatric Nephrology (Berlin, Germany)|March 8, 2011
Plasma from a case of recurrent idiopathic FSGS perturbs non-muscle myosin IIA (MYH9 protein) in human podocytesSima Babayeva, Michelle Miller, Yulia Zilber, et al.American Journal of Physiology. Renal Physiology|January 1, 2016
Novel unbiased assay for circulating podocyte-toxic factors associated with recurrent focal segmental glomerulosclerosisNadezda Kachurina, Chen-Fang Chung, Erin Benderoff, et al.Plos One|May 17, 2019
Intrinsic tumor necrosis factor-α pathway is activated in a subset of patients with focal segmental glomerulosclerosisChen-Fang Chung, Thomas Kitzler, Nadezda Kachurina, et al.Journal of the American Society of Nephrology : JASN|October 22, 2003
Ureteric bud apoptosis and renal hypoplasia in transgenic PAX2-Bax fetal mice mimics the renal-coloboma syndromeAlison Dziarmaga, Patsy Clark, Cherie Stayner, et al.The Journal of Biological Chemistry|December 22, 2005
PAX2 activates WNT4 expression during mammalian kidney developmentElena Torban, Alison Dziarmaga, Diana Iglesias, et al.Kidney International. Supplement|January 31, 2009
Treatment options for HUS secondary to Escherichia coli O157:H7Martin BitzanPageof 14